Viewing Study NCT03112694


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-01-05 @ 12:20 AM
Study NCT ID: NCT03112694
Status: COMPLETED
Last Update Posted: 2020-06-02
First Post: 2017-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Sponsor: Ipsen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module